CRISPR/Cas9 deletion of SOX2 regulatory region 2 (SRR2) decreases SOX2 malignant activity in glioblastoma

  1. Saenz-Antoñanzas, A.
  2. Moncho-Amor, V.
  3. Auzmendi-Iriarte, J.
  4. Elua-Pinin, A.
  5. Rizzoti, K.
  6. Lovell-Badge, R.
  7. Matheu, A.
Aldizkaria:
Cancers

ISSN: 2072-6694

Argitalpen urtea: 2021

Alea: 13

Zenbakia: 7

Mota: Artikulua

DOI: 10.3390/CANCERS13071574 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak